TwoStep Therapeutics raised $62.5 million in an oversubscribed Series A financing, securing funding for their first-in-class peptide-drug conjugate.
Amount Raised
$62.5 Million
Round Type
Series A
Palo AltoBiotechnologyInvestors
Description
TwoStep Therapeutics has announced the closing of its oversubscribed $62.5 million Series A financing. This funding follows the FDA clearance of the IND for their first-in-class peptide-drug conjugate. The capital will support the advancement of their innovative therapeutic pipeline.
Who to call at TwoStep Therapeutics, and when
A new round usually means TwoStep Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day TwoStep Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at TwoStep Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at TwoStep Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment TwoStep Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansTwoStep Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.